Discontinuation report PROBUPHINE

Last updated on 2023-07-04 History
Report ID 171025
Drug Identification Number 02474921
Brand name PROBUPHINE
Common or Proper name Buprenorphine hydrochloride implant
Company Name KNIGHT THERAPEUTICS INC.
Market Status CANCELLED POST MARKET
Active Ingredient(s) BUPRENORPHINE HYDROCHLORIDE
Strength(s) 80MG
Dosage form(s) IMPLANT
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size Implant kit has 4 individually pouched Probuphine implants.
ATC code N07BC
ATC description
Reason for discontinuation Other (Please describe in comments)
Anticipated discontinuation date 2023-05-30
Actual discontinuation date 2023-07-03
Remaining supply date 2023-05-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Our current inventory of Probuphine (80 mg buprenorphine hydrochloride implant) is anticipated to deplete by May 2023.
Company comments We regret to announce that following inventory depletion, this product will be officially discontinued and will no longer be marketed in Canada. The reason for discontinuation is due to the inability to successfully acquire continued supply and is unrelated to any safety concerns.
Health Canada comments
Tier 3 Status No
Contact Address 3400 DE MAISONNEUVE BLVD W
MONTREAL, QUEBEC
CANADA H3Z 3B8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2023-07-04 French Compare
v13 2023-07-04 English Compare
v12 2022-10-04 French Compare
v11 2022-10-04 French Compare
v10 2022-10-04 English Compare
v9 2022-10-04 French Compare
v8 2022-10-04 English Compare
v7 2022-10-04 English Compare
v6 2022-10-04 French Compare
v5 2022-10-04 English Compare
v4 2022-10-04 French Compare
v3 2022-10-04 French Compare
v2 2022-10-04 English Compare
v1 2022-10-04 English Compare

Showing 1 to 14 of 14